Energy-based devices for treatment of melasma

Juliana Merheb Jordão, Priscila Regina Orso Rebellato


Melasma, as a pigmentation disorder, induces significant stress to the patients and its recurrent nature remains a challenge in clinical practice. Treatment is based on a variety of mechanisms to prevent and/or stop the pigment production process by destroying the deposited pigment for removal or release, by peeling cells to improve their turnover, and by reducing inflammation. The use of appropriate devices and correct settings are crucial in the treatment of melasma. Cases unresponsive to topical bleaches or chemical peels should be referred for laser therapy. It is important that a maintenance therapy to avoid the recurrence of melasma be indicated. In this paper, we review energy-based devices for melasma treatment.


Lasers; melasma treatment

Full Text:


Included Database


Kar HK, Gupta L, Chauhan A. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma. Indian J Dermatol Venereol Leprol 2012; 78(2): 165–171. doi: 10.41 03/0378-6323.93633.

Gokalp H, Akkaya AD, Oram Y. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective? J Cosmet Dermatol 2016; 15(4): 420–426. doi: 10.1111/jocd.12253.

Bevec T. Treating melasma with sub-thermolytic Q-switched Nd:YAG. J LAHA 2011; 2011(1): 53–55.

Kwon SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J

Mol Sci 2016; 17(6): 824. doi: 10.3390/ijms17060824.

Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: Management update and expert opinion. Skin Therapy Lett 2016; 21(1): 1–7.

Majid I, Haq I, Imran A, Keen A, Aziz K, et al. Proposing melasma severity index: A new, more practical, of-fice-based scoring system for assessing the severity of melasma. Indian J Dermatol 2016; 61(1): 39–44. doi: 10.4103/0019-5154.174024.

Rodrigues M, Pandya AG. Melasma: Clinical diagnosis and management options. Australas J Dermatol 2015; 56(3): 151–163. doi: 10.1111/ajd.12290.

Karsai S, Fischer T, Pohl L, Schmitt L, Buhck H, et al. Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a pro-spective controlled single-blinded trial in 51 patients. J Eur Acad Dermatol Venereol 2012; 26(4): 470–476. doi: 10.1111/j.1468-3083.2011.04100.x.

Lee BW, Schwartz RA, Janniger CK. Melasma. G Ital Dermatol Venereol 2017; 152(1): 36–45. doi: 10.23736/S0392-0488.16.05425-0.

Fabi SG, Friedmann DP, Massaki ABN, Goldman MP. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Lasers Surg Med 2014; 46(7): 531–537. doi: 10.1002/lsm.22263.

Arora P, Sarkar R, Garg VK, Arya L. Lasers for the treatment of melasma and post-inflammatory hyperpig-mentation. J Cutan Aesthet Surg 2012; 5(2): 93–103. doi: 10.4103/0974-2077.99436.

Tian WC. Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser. J Cosmet Laser Ther 2016; 18(2): 72–74. doi: 10.3109/14764172.2015.10636 62.

Dunbar S, Posnick D, Bloom B, Elias C, Zito P, et al. Energy-based device treatment of melasma: An update and review of the literature. J Cosmet Laser Ther 2017; 19(1): 2–12. doi: 10.1080/14764172.2016.1229485.

Jang YH, Park JY, Park YJ, Kang HT. Changes in melanin and melanocytes in mottled hypopigmentation after low-fluence 1,064-nm Q-switched Nd:YAG laser treat-ment for melasma. Ann Dermatol 2015; 27(3): 340–342. doi: 10.5021/ad.2015.27.3.340.

Kauvar ANB. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers. Lasers Surg Med 2012; 44(2): 117–124. doi: 10.1002/lsm.21156.

Chen YT, Chang CC, Hsu CR, Shen JH, Shih CJ, et al. Combined vitamin C sonophoresis and neodymium-doped yttrium aluminum garnet (NdYAG) laser for facial hyperpigmentation: An outcome observation study in Asian patients. Indian J Dermatol Venereol Leprol 2016; 82(5): 587. doi: 10.4103/0378-6323.182806.

Parra CAH, Careta MF, Valente NYS, de Sanches Osório NEG, Torezan LAR. Clinical and histopathologic assess-ment of facial melasma after low-fluence QS Nd:YAG laser. Dermatol Surg 2016; 42(4): 507–512. doi: 10.1097/DSS.0000000000000653.

Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH. Low-fluence Q-switched neodymium-doped yttrium alu-minum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatol Surg 2010; 36(6): 909–918. doi: 10.1111/j.1524-4725.20 10.01523.x.

Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg 2010; 36(1): 76–87. doi: 10.1111/j.1524-4725.2009.01383.x.

Wong Y, Lee SSJ, Goh CL. Hypopigmentation induced by frequent low-fluence, large-spot-size QS Nd:YAG laser treatments. Ann Dermatol 2015; 27(6): 751–755. doi: 10.5021/ad.2015.27.6.751.

Hilton S, Heise H, Buhren BA, Schrumpf H, Bölke E, et al. Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser. Eur J Med Res 2013; 18(1): 43. doi: 10.1186/2047-783 X-18-43.

Lee MK, Min KS, Park EJ, Kim KH, Kim KJL. A retrospective analysis of the treatment of melasma using a fractional long-pulsed alexandrite laser in Korean patients. Dermatol Surg 2016; 42(8): 952–960. doi: 10.1097/D SS.0000000000000767.

Choi CP, Yim SM, Seo SH, Ahm HH, Kye YC, et al. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd-YAG laser vs. low-fluence Q-switched Nd:YAG laser mono-therapy. J Cosmet Laser Ther 2015; 17(1): 2–8. 10.3109/14764172.2014.957217.

Barysch MJ, Rümmelein B, Kolm I, Karpova MB, Schönewolf N, et al. Split-face study of melasma patients treated with non-ablative fractionated photothermolysis (1540 nm). JEADV 2012; 26(4): 423–430. doi: 10.1111/j.1468-3083.2011.04086.x.

Attwa E, Khater M, Assaf M, Haleem MA. Melasma treatment using an erbium:YAG laser: A clinical, im-munohistochemical, and ultrastructural study. Int J Der-matol 2015; 54(2): 235–244. doi: 10.1111/ijd.12477.

Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25(2): 121–123. doi: 10.1046/j.1524-4725.1999.08103.x.

Trelles M, Velez M, Gold M. The treatment of melasma with topical creams alone, CO2 fractional ablative resur-facing alone, or a combination of the two: A comparative study. J Drugs Dermatol 2010; 9(4): 315–322.

Zoccali G, Piccolo D, Allegra P, Giuliani M. Melasma treated with intense pulsed light. Aesthetic Plast Surg 2010; 34(4): 486–493. doi: 10.1007/s00266-010-9485-y.

Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd: YAG laser treatment in melasma patients. Ann Dermatol 2012; 24(3): 267–273. doi: 10.5021/ad.2012.24.3.267.

Chung JY, Choi M, Lee JH, Cho S, Lee JH. Pul- se-in-pulse intense pulsed light for melasma treatment: A pilot study. Dermatol Surg 2014; 40(2): 162–168. doi: 10.1111/dsu.12414.

Moreno Arias GA, Fernando J. Intense pulsed light for melanocytic lesions. Dermatol Surg 2001; 27(4): 397–400. doi: 10.1046/j.1524-4725.2001.00315.x.

Wang CC, Hui CY, Sue YM, Wong WR, Hong SH. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg 2004; 30(9): 1196–1200. doi: 10.1111/j.1524-4725.2004.30371.x.

Bae MI, Park JM, Jeong KH, Lee MH, Shin MK. Effectiveness of low-fluence and short-pulse intense pulsed light in the treatment of melasma: A randomized study. J Cosmet Laser Ther 2015; 17(6): 292–295. doi: 10.3109/14764172.2015.1027228.

Robinson DM, Friedman PM, Li JY, Geddes ER. A

review of melasma treatment focusing on laser and light devices. Semin Cutan Med Surg 2016; 35(4): 223–232. doi: 10.12788/j.sder.2016.060.

Kalil C, Campos V. Manual prático do laser e outras fontes de energia eletromagnética na dermatologia (Portuguese) [Practical manual of laser and other electromagnetic energy sources in dermatology]. 1st ed. Rio de Janeiro, Brazil: Elsevier; 2017.

Tanghetti EA. The histology of skin treated with a picosecond alexandrite laser and a fractional lens array. Lasers Surg Med 2016; 48(7): 646–652. doi: 10.10 02/lsm.22540.

Friedman D. Novel method for treatment of melasma with a 532nm picosecond laser. In: 2016 Late-Breaking Abstracts. Lasers Surg Med 2016; 48(4): 421. doi: 10.1002/lsm.22526.



  • There are currently no refbacks.